OrbiMed Capital GP V LLC, 10% Owner at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 200,772 shares at $30.77 ($6.2M) on 2018-05-18, disclosed to the SEC on 2018-05-21.
Open-market sale of $6.2M RYTM by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.77 | 69,136 | $2.1M | 34.4% |
| 2 | $30.77 | 69,136 | $2.1M | 34.4% |
| 3 | $31.01 | 62,500 | $1.9M | 31.3% |
| Total | $30.84 avg | 200,772 | $6.2M | 100% |
| Filing → |
| CMPX | BUY | 2022-05-10 | $339K | — | Filing → |
| CRVS | SELL | 2021-09-22 | $13.5M | — | Filing → |
| ARPO | SELL | 2020-12-10 | $42K | — | Filing → |